[1] Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: Updates in pathogenesis, diagnosis, and management. Am J Gastroenterol,2017, 112(6):838-846. [2] Ramanathan R, Ibdah JA. Mitochondrial dysfunction and acute fatty liver of pregnancy. Int J Mol Sci,2022, 23(7):3595. [3] Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases. Hepatology,1985, 5(6):1149-1158. [4] Knight M, Nelson-Piercy C,Kurinczuk JJ, et al. UK obstetric surveillance system: A prospective national study of acute fatty liver of pregnancy in the UK. Gut,2008, 57(7):951-967. [5] Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol,2005, 192(5):1416-1419. [6] Gao Q, Qu X, Chen X, et al. Outcomes and risk factors of patients with acute fatty liver of pregnancy: a multicentre retrospective study. Singapore Med J, 2018, 59(8):425-430. [7] Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut,2002, 51(6):876-880. [8] 中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171. [9] Mehta RL,Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care,2007, 11(2): R31. [10] Reyes H, Sandoval L, Wain stein A, et al. Acute fatty of pregnancy a clinical study of 12 episodes in 11 patient. Gut,1994, 35:101-106 . [11] Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicularsteatosis? Gut,2011, 60(1):138-139. [12] Naoum EE, Leffert LR, Chitilian HV, et al. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications, and obstetrical management. Anesthesiology,2019,130(3):446-461. [13] Goel A, Eapen CE, Mathews J, et al. Acute fatty liver of pregnancy: better understanding of pathogenesis and earlier clinical recognition results in improved maternal outcomes. EMJ Hepatol, 2018, 69(1):72-79. [14] Vigil-deGracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med, 2011, 24(9):1143-1146. [15] Goel A, Nair SC, Viswabandya A, et al. Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders. Indian J Gastroenterol,2013, 32(4):268-271. [16] Baju N M, Henry N, Innah S J. Management of coagulopathy in acute fatty liver of pregnancy. J Case Rep,2016, 6:317-320. [17] Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol,2013, 209:456e1-7. [18] Bernal W,Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol,2013, 59(1):74-80. [19] Tang W, Huang Z, Wang Y, et al. Effect of plasma exchange on hepatocyte oxidative stress, mitochondria function, and apoptosis in patients with acute fatty liver of pregnancy. Artif Organs,2012, 36(3): E39-47. [20] Kushner T, Tholey D, Dodge J, et al. Outcomes of liver transplantation for acute fatty liver disease of pregnancy. Am J Transplant, 2019,19(7):2101-2107. |